BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9049377)

  • 21. Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.
    Yamada H; Nagao C; Haredy AM; Mori Y; Mizuguchi K; Yamanishi K; Okamoto S
    Antiviral Res; 2014 Nov; 111():69-77. PubMed ID: 25234090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
    Kongkamnerd J; Cappelletti L; Prandi A; Seneci P; Rungrotmongkol T; Jongaroonngamsang N; Rojsitthisak P; Frecer V; Milani A; Cattoli G; Terregino C; Capua I; Beneduce L; Gallotta A; Pengo P; Fassina G; Miertus S; De-Eknamkul W
    Bioorg Med Chem; 2012 Mar; 20(6):2152-7. PubMed ID: 22342267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of glycosylation at Asn144 alters the substrate preference of the N8 influenza A virus neuraminidase.
    Saito T; Kawano K
    J Vet Med Sci; 1997 Oct; 59(10):923-6. PubMed ID: 9362042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in neuraminidase genes of influenza A (H3N2) viruses.
    Xu X; Cox NJ; Bender CA; Regnery HL; Shaw MW
    Virology; 1996 Oct; 224(1):175-83. PubMed ID: 8862412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of enzyme activity in a site-directed mutant of influenza neuraminidase compared to expressed wild-type protein.
    Lentz MR; Air GM
    Virology; 1986 Jan; 148(1):74-83. PubMed ID: 2417413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS; Air GM
    Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Accessing the features of surface neuraminidase (N1) of influenza A virus presenting on the platforms for anti-NA Abs screening].
    Huang L; Qin K; Zhou JF; Shu YL; Wei H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):1-4. PubMed ID: 23855116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues.
    Ho HT; Hurt AC; Mosse J; Barr I
    Antiviral Res; 2007 Dec; 76(3):263-6. PubMed ID: 17868928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reduction of the functional match of influenza virus hemagglutinin and neuraminidase after reassortation of genes].
    Rudneva IA; Gambarian AS; Shilov AA; Sinitsyn BV; Kropotkina EA; Il'iushina NA; Kaverin NV
    Mol Biol (Mosk); 2001; 35(3):500-3. PubMed ID: 11443933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence of the neuraminidase gene of an avian influenza A virus (A/parrot/ulster/73, H7N1).
    Steuler H; Rohde W; Scholtissek C
    Virology; 1984 May; 135(1):118-24. PubMed ID: 6328743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosylation and surface expression of the influenza virus neuraminidase requires the N-terminal hydrophobic region.
    Markoff L; Lin BC; Sveda MM; Lai CJ
    Mol Cell Biol; 1984 Jan; 4(1):8-16. PubMed ID: 6700587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
    White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
    J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase.
    Borg J; Nevsten P; Wallenberg R; Stenstrom M; Cardell S; Falkenberg C; Holm C
    J Biotechnol; 2004 Oct; 114(1-2):21-30. PubMed ID: 15464595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic structure and variation in an influenza virus N9 neuraminidase.
    Webster RG; Air GM; Metzger DW; Colman PM; Varghese JN; Baker AT; Laver WG
    J Virol; 1987 Sep; 61(9):2910-6. PubMed ID: 3612957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion mutation in the signal anchor domain activates cleavage of the influenza virus neuraminidase, a type II transmembrane protein.
    Hogue BG; Nayak DP
    J Gen Virol; 1994 May; 75 ( Pt 5)():1015-22. PubMed ID: 8176363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis.
    Albohy A; Li MD; Zheng RB; Zou C; Cairo CW
    Glycobiology; 2010 Sep; 20(9):1127-38. PubMed ID: 20511247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of neuraminidase gene of influenza virus H1N1 in baculovirus-expression system].
    Yao LH; Fu JQ; Chen AJ; Liu XY; Xu PW; Guo JQ; Zhang LC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr; 27(2):81-4. PubMed ID: 24044206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuraminic acid is involved in the binding of influenza C virus to erythrocytes.
    Herrler G; Rott R; Klenk HD
    Virology; 1985 Feb; 141(1):144-7. PubMed ID: 3976175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.
    Tanimoto T; Nakatsu R; Fuke I; Ishikawa T; Ishibashi M; Yamanishi K; Takahashi M; Tamura S
    Vaccine; 2005 Aug; 23(37):4598-609. PubMed ID: 15964668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary structure of the full-length DNA copy of the neuraminidase gene in the avian influenza virus of the N7 antigenic subtype].
    Grinev AA; Petrov NA; Golovin SIa; Mamaev LV; Mikriukova TP
    Bioorg Khim; 1988 Mar; 14(3):416-8. PubMed ID: 3382443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.